Category:Antineoplastic and immunomodulating drug stubs
 | This category is maintained by WikiProject Stub sorting. Please propose new stub templates and categories here before creation. |
 | This category is for stub articles relating to antineoplastic and immunomodulating drugs (ATC code L). You can help by expanding them. To add an article to this category, use {{antineoplastic-drug-stub}} instead of {{stub}}. |
Pages in category "Antineoplastic and immunomodulating drug stubs"
The following 200 pages are in this category, out of approximately 412 total. This list may not reflect recent changes.
(previous page) (next page)0–9
A
- Abetimus
- Δ4-Abiraterone
- Acefluranol
- Aceglatone
- Acetothiolutamide
- Acivicin
- Aclarubicin
- Acolbifene
- Acridine carboxamide
- Actarit
- Adavosertib
- Adecatumumab
- Aderbasib
- ADH-1
- Adozelesin
- Afelimomab
- Alacizumab pegol
- Alazopeptin
- Albinterferon
- Alestramustine
- Alvocidib
- AMG 319
- Amikhelline
- Amonafide
- Amphinex
- Amrubicin
- Amsacrine
- Anatumomab mafenatox
- Ancestim
- Androgen receptor degrader
- Annamycin
- Anti-CD3 monoclonal antibody
- Anti-CD19 immunotoxin
- Anticarcinogen
- Antiprogestogen
- Apolizumab
- Arctigenin
- Aselizumab
- Asoprisnil
- Atamestane
- Atorolimumab
- Atrimustine
- Aumolertinib
- Avutometinib
B
C
D
- Dacetuzumab
- Dactolisib
- Dalpiciclib
- Damnacanthal
- Darusentan
- Darvadstrocel
- Daunorubicin/cytarabine
- Decernotinib
- Defactinib
- Denileukin diftitox
- N-Desmethylapalutamide
- N-Desmethylenzalutamide
- N-Desmethyltamoxifen
- Detumomab
- DHA-paclitaxel
- Dibrospidium chloride
- N,N-Didesmethyltamoxifen
- Dihydrofolate reductase inhibitor
- Dimestrol
- Disitamab vedotin
- Drozitumab
- Dusigitumab
E
- Ecromeximab
- Edrecolomab
- Efalizumab
- Eflapegrastim
- Eganelisib
- Elapegademase
- Elesclomol
- Elsamitrucin
- Elsilimomab
- EM-5854
- Enavatuzumab
- Enocitabine
- Ensituximab
- Entinostat
- Entospletinib
- Epoxomicin
- Epratuzumab
- Erbulozole
- Ertumaxomab
- Estradiol mustard
- Estramustine
- Estromustine
- Etalocib
- Etanidazole
- Etaracizumab
- Ethandrostate
- Ethinylandrostenediol
- 17α-Ethynyl-3α-androstanediol
- 17α-Ethynyl-3β-androstanediol
- Etirinotecan pegol
- Etoglucid
- Etrolizumab
- Exatecan
F
G
I
- ICI-85966
- ICI-164384
- Icrucumab
- Idarubicin
- Idoxifene
- Idramantone
- IFL (chemotherapy)
- Iguratimod
- Imexon
- Indium (111In) altumomab pentetate
- Indium (111In) capromab pendetide
- Indium (111In) igovomab
- Indium (111In) satumomab pendetide
- Indusatumab vedotin
- Inolimomab
- Interferon alfa
- Interferon alfa-2b
- Interferon alfacon-1
- Interferon alpha-n3
- Intetumumab
- Iratumumab
- Itolizumab